Effect of Colchicine Treatment on Clinical Course in Children with PFAPA Syndrome
Klinische Pädiatrie · 2024-09 · 236 (05) · 296-300
DOI: 10.1055/a-2274-9046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, online erschienen am 06.05.2024. Verfasst von İlknur Bagrul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Rheumatology, Ankara Etlik Integrated Health Campus, ANKARA, Turkey. Hauptthemen laut MEDLINE: Colchicine, Stomatitis, Aphthous, Lymphadenitis, Pharyngitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA) is the most common periodic fever condition in children. There is no consensus on treatment to prevent attacks and reduce their frequency. In this study, we aimed to evaluate the effectiveness of colchicine treatment in PFAPA syndrome. In addition, we described the demographic and clinical features of PFAPA patients. Materials and Methods We retrospectively analyzed 58 PFAPA patients who were started on colchicine treatment between January 2017 and January 2022. Demographic data, clinical features, laboratory tests, genetic analysis of MEditerranean FeVer (MEFV) mutations, and autoinflammatory disease activity index (AIDAI) scores of all patients were evaluated. In addition, patients were divided into two groups according to MEFV variants and compared.
Results
Attack frequency, duration, and AIDAI scores decreased in all patients after colchicine treatment. Duration of follow-up was 13.53±6.65 months. The median±IQR age at diagnosis was 3.2 (2–5) years. Thirty three (56.9%) patients had heterozygous mutations of MEFV. The most common MEFV variants were M694V (63.6%). There was no significant difference between the two groups in terms of colchicine responses.
Conclusion
Colchicine treatment is effective and safe in patients with PFAPA who have frequent attacks. No association was established between the presence of heterozygous mutations of MEFV and colchicine response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Rheumatology, Ankara Etlik Integrated Health Campus, ANKARA, Turkey.
- Department of Pediatric Nephrology, Dr Sami Ulus Gynecology Obstetrics and Child Health and Diseases Training and Research Hospital, Ankara, Turkey.
Zitieren
APA
Bagrul, İ., Aydin, E. A., Tuncez, S., Baglan, E., Özdel, S., & Bülbül, M. (2024). Effect of Colchicine Treatment on Clinical Course in Children with PFAPA Syndrome. Klinische Pädiatrie, 236(05), 296-300. https://doi.org/10.1055/a-2274-9046
Vancouver
Bagrul İ, Aydin EA, Tuncez S, Baglan E, Özdel S, Bülbül M. Effect of Colchicine Treatment on Clinical Course in Children with PFAPA Syndrome. Klinische Pädiatrie. 2024;236(05):296-300. doi:10.1055/a-2274-9046
BibTeX
@article{Bagrul2024,
author = {Bagrul, İlknur and Aydin, Elif Arslanoglu and Tuncez, Serife and Baglan, Esra and Özdel, Semanur and Bülbül, Mehmet},
title = {Effect of Colchicine Treatment on Clinical Course in Children with PFAPA Syndrome},
journal = {Klinische Pädiatrie},
year = {2024},
volume = {236},
number = {05},
pages = {296--300},
doi = {10.1055/a-2274-9046}
}
EUVIMED